ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1716

Predictors of Unacceptable Pain and Unacceptable Pain with Low Inflammation in Early Rheumatoid Arthritis

Anna Eberhard1, Tor Olofsson2, Stefan Bergman3, Thomas Mandl4 and Carl Turesson5, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Clinical Sciences Lund, Rheumatology, Lund University, Sweden. Department of Rheumatology, Skåne University Hospital, Lund, Sweden., Lund, Sweden, 3Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden, 4Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, 5Rheumatology, Department of Clinical Sciences Malmö, Lund University, Department of Rheumatology, Skåne University Hospital, Malmö, Sweden., Malmö, Sweden

Meeting: ACR Convergence 2020

Keywords: pain, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Pain is a common and debilitating symptom in patients with rheumatoid arthritis (RA). In early RA it is usually due to ongoing inflammation and synovitis, but over time a substantial proportion of patients experience pain without laboratory or clinical signs of inflammation. 
The objective of this study was to investigate predictors of unacceptable pain and unacceptable pain with low inflammation one year after diagnosis in patients with RA.

Methods: Consecutive patients with early RA (symptom duration < 12 months, fulfilling the 1987 ACR criteria and/or the 2010 ACR/EULAR criteria) were recruited between January 2012 and March 2016 from a defined geographical area. Patients were managed according to usual care, and were followed for one year after diagnosis. Pain was assessed using a visual analogue scale (VAS; 0-100 mm). Unacceptable pain was defined as VAS pain > 40 based on the patient acceptable symptom state (PASS) (1), and low inflammation as CRP < 10 mg/l (2). Baseline predictors of unacceptable pain, and unacceptable pain with low inflammation, were evaluated using logistic regression analysis.

Results: A total of 263 patients with early RA (mean age 59 years, 73 % female, 67 % anti-CCP positive, median symptom duration 5 months) were included, and 183 attended the 1-year follow-up. After one year 32 % had unacceptable pain and 22 % had unacceptable pain with low inflammation, the latter thus accounting for 69 % of all unacceptable pain. High scores for the Health Assessment Questionnaire (HAQ) disability index at baseline, and female sex were associated with unacceptable pain (Table 1) and also with unacceptable pain with low inflammation (Table 2) at 1 year in univariate analysis, whereas there were no such associations for swollen joint count or laboratory markers of inflammation (Table 1, Table 2). In multivariate logistic regression analysis, there was an independent association between higher HAQ and unacceptable pain after 1 year [adjusted odds ratio (OR); 1.56 per SD (95 % CI 1.06-2.28) (SD 0.65)] with a similar trend for patients with unacceptable pain and low inflammation (OR 1.47 per SD; 95 % CI 0.98 – 2.21).

Conclusion: Almost 1/3 of early RA patients reported unacceptable pain one year after diagnosis, implying the need for improvement in pain treatment. Patients with high self-reported disability at baseline were at increased risk of unacceptable pain at 1 year. This could be due to ineffective coping strategies and inactivity. The association between female sex and persistent unacceptable pain could indicate sex differences in disease severity, or in propensity for chronic pain. Unacceptable pain 1 year after RA diagnosis was not associated with any objective baseline measures of disease activity, indicating the need to find other predictors for long time severity of pain.

References

  1. Tubach et al. Arthrits Care Res 2012; 64: 1699-707.
  2. Olofsson et al. Arthritis Care Res. Online First 20 May 2020. doi:100.1002/acr.242664.


Disclosure: A. Eberhard, None; T. Olofsson, Merck Sharp & Dohme, 9, Eli Lilly, 9; S. Bergman, None; T. Mandl, Novartis, 3; C. Turesson, Roche, 1, 2, Abbvie, 1, Pfizer, 1, Bristol-Myers Squibb, 1, 2.

To cite this abstract in AMA style:

Eberhard A, Olofsson T, Bergman S, Mandl T, Turesson C. Predictors of Unacceptable Pain and Unacceptable Pain with Low Inflammation in Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/predictors-of-unacceptable-pain-and-unacceptable-pain-with-low-inflammation-in-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-unacceptable-pain-and-unacceptable-pain-with-low-inflammation-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology